Are new asthma therapies needed

Journal of Clinical Pharmacology

Volumn 39, Issue 3, 1999, Pages 230-236

  O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FORMOTEROL; GLUCOCORTICOID; METHACHOLINE; PLACEBO; SALBUTAMOL;

ASTHMA; CATARACT; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DYSPHONIA; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MEDICAL PRACTICE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SYMPTOMATOLOGY; THRUSH; TREATMENT PLANNING;

ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG EVALUATION; HUMANS;

EID: 0033051922     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Sheffer AL, Bartal M, Bousquet J, Carrasco E, et al: Global strategy for asthma management and prevention. National Institutes of Health 1995;95-3659:70-114.
2. British Thoracic Society: Guidelines on the management of asthma. Thorax 1994;48:S1-S24.
3. Japanese Society of Allergology: Guidelines for the diagnosis and management of bronchial asthma. Committee on the Definition, Treatment, and Management of Bronchial Asthma. Allergy 1995;50:S1-S42.
4. Ernst P, Fitzgerald JM, Spier S: Canadian Asthma Consensus Conference summary of recommendations. Canadian Respiratory Journal 1996;3:89-100.
5. Peat JK, Woolcock AJ, Cullen K: Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-179.
6. Barnes PJ, Pedersen S, Busse WW: Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998;157:1-53.
7. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA: Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-899.
8. Laitinen LA, Laitinen A, Haahtela T: A comparative study of the effects of an inhaled corticosteroid, budesonide, and of an inhaled B2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 1992;90:32-42.
9. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF: Effect of 22 months of treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness and symptoms in patients with asthma. Am Rev Respir Dis 1992;146:547-554.
10. Juniper E, Kline P, Vanzieleghem M, Hargreave F: Reduction of budesonide after a year if increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991;87:483-489.
11. Cockcroft DW, Murdock KY: Protective effect of inhaled albuterol, cromolyn, beclomethasone, and placebo on allergen-induced early asthmatic responses, late asthmatic responses and allergen-induced increases in broncial responsiveness to inhaled histamine. J Allergy Clin Immunol 1987;79:734-740.
12. Anderson S, Seale JP, Ferris L, Schoeffel R, Lindsay DA: An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol 1979;64:612-624.
13. Barnes PJ, Pedersen S: Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148:S1-S26.
14. Pedersen S, O'Byrne PM: A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52:1-34.
15. Drazen J, Israel E: Treating mild asthma: when are inhaled steroids indicated? N Engl J Med 1994;331:737-738.
16. Haahtela T, Jarvinen M, Tuomo K, et al: Comparison of a B2 antagonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392.
17. O'Byrne PM, Cuddy L, Taylor DW, Birch S, Morris J, Syrotiuk J: The clinical efficacy and cost benefit of inhaled corticosteroids as therapy in patients with mild asthma in primary care practice. Can Resp J 1996;3:169-175.
18. Toogood JH, Jennings B, Greenway RW, Chuang L: Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980;65:145-153.
19. Shaw NJ, Edmunds AT: Inhaled beclomethasone and oral candidiasis. Arch Dis Child 1986;61:788-790.
20. Wong J, Black P: Acute adrenal insufficiency associated with high dose inhaled steroids. B.M.J. 1992;304:1415.
21. Zwaan CM, Odink RJH, Delemarre-van de Waal HA, Dankert-Roelse JE, Bokma JA: Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy. Lancet 1992;340:1289-1290.
22. Toogood JH, Markov AE, Baskerville JC, Dyson C: Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol 1993;91:571-579.
23. Simons FE, Persaud MP, Gillespie CA, Cheang M, Shuckett EP: Absence of posterior subcapsular cataracts in young patients treated with inhaled corticosteroids. Lancet 1993;342:776-768.
24. Balfour-Lynn L: Effect of asthma on growth and puberty. Pediatrician 1987;24:237-241.
25. Martin AJ, Landau LI, Phelan PD: The effects on growth of childhood asthma. Acta Paediat Scand 1981;70:683-688.
26. Reed CE, Offord KP, Nelson HS, Li JT, Tinkelman DG: Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. J Allergy Clin Immunol 1998;101:14-23.
27. Agertoft L, Pedersen S: Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
28. Mak V, Melchor R, Spiro SG: Easy bruising as a side effect of inhaled corticosteroids. Eur Respir J 1992;86:608-610.
29. Sears MR, Taylor DR, Print CG, et al: Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-1396.
30. Taylor DR, Sears MR, Herbison GP, et al: Regular inhaled B-agonists in asthma: effects on exacerbations and lung function. Thorax 1993;48:134-138.
31. Drazen JM, Israel E, Boushey HA, et al: Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-847.
32. Crane J, Pearce N, Flatt A, et al: Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989;1:917-922.
33. Spitzer WO, Suissa S, Ernst P, et al: The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-506.
34. Krahn J, Koeter GH, van der Mark TW, Sluiter HJ, De Vries K: Changes in bronchial hyperactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985;76:628-636.
35. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE: Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;1:554-548.
36. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ: Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-1203.
37. O'Connor BJ, Aikman SL, Barnes PJ: Tolerance to the nonbronchodilating effects of inhaled beta2-agonists in asthma. N Engl J Med 1992;327:1204-1208.
38. Becker AB, Simons ER, McMillan JL, Faridy T: Formeterol, a new long lasting selective B2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. J Allergy Clin Immunol 1989;84:891-895.
39. Ramsdale EH, Otis J, Klein W, Hargreave FE, O'Byrne PM: The effect of a long acting B2-adrenoceptor agonist, formoterol, on methacholine airway responsiveness in asthmatic subjects. Am Rev Respir Dis 1991;143:998-1001.
40. Woolcock AJ, Lundback B, Ringdal N, Jacques LA: Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
41. Greening AP, Ind PW, Northfield M, Shaw G: Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
42. Pauwels RA, Lofdahl C-G, Postma DS, O'Byrne PM, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-1411.
43. Simons FE, Gerstner TV, Cheang MS: Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99:655-659.